{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:20:44Z","timestamp":1784838044072,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.molmed.2016.10.002","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T22:15:52Z","timestamp":1478297752000},"page":"1000-1011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Cell-Intrinsic Barriers of T Cell-Based Immunotherapy"],"prefix":"10.1016","volume":"22","author":[{"given":"Hazem E.","family":"Ghoneim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben A.","family":"Youngblood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2016.10.002_bib0400","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0405","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/362758a0","article-title":"Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells","volume":"362","author":"Moskophidis","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.10.002_bib0410","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0415","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","article-title":"Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I\u2013peptide complexes","volume":"187","author":"Gallimore","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0420","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.170.1.477","article-title":"Ablation of CD8 and CD4 T cell responses by high viral loads","volume":"170","author":"Fuller","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0425","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0430","doi-asserted-by":"crossref","first-page":"10249","DOI":"10.1128\/JVI.74.21.10249-10255.2000","article-title":"A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon","volume":"74","author":"Goepfert","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0435","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0440","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/9525","article-title":"Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients","volume":"5","author":"Lee","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0445","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2016.10.002_bib0450","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.10.002_bib0455","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0460","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2016.10.002_bib0465","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molmed.2016.10.002_bib0470","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0475","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2016.10.002_bib0480","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.molmed.2016.10.002_bib0485","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2016.10.002_bib0490","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4161\/onci.22524","article-title":"How do CARs work? Early insights from recent clinical studies targeting CD19","volume":"1","author":"Davila","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.molmed.2016.10.002_bib0495","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.10.002_bib0500","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0229-y","article-title":"Current status and perspectives in translational biomarker research for PD-1\/PD-L1 immune checkpoint blockade therapy","volume":"9","author":"Ma","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0510","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.molmed.2016.04.008","article-title":"Learning from PD-1 resistance: new combination strategies","volume":"22","author":"Bu","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0515","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2016.4059","article-title":"Association of pembrolizumab with tumor response and survival among patients with advanced melanoma","volume":"315","author":"Ribas","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.molmed.2016.10.002_bib0520","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0525","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.10.002_bib0530","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.molmed.2016.10.002_bib0535","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","article-title":"Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade","volume":"105","author":"Blackburn","year":"2008","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2016.10.002_bib0540","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2016.10.002_bib0545","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.10.002_bib0550","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1128\/JVI.00889-12","article-title":"Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection","volume":"86","author":"Angelosanto","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0555","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni.2606","article-title":"T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion","volume":"14","author":"Utzschneider","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.06.015","article-title":"Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8+ T cells","volume":"35","author":"Youngblood","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2016.10.002_bib0565","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4049\/jimmunol.1203161","article-title":"Cutting edge: prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells","volume":"191","author":"Youngblood","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0570","doi-asserted-by":"crossref","first-page":"8934","DOI":"10.1128\/JVI.00798-16","article-title":"Demethylation of the PD-1 promoter is imprinted during the effector phase of CD8 T cell exhaustion","volume":"90","author":"Ahn","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0575","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2016.10.002_bib0580","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0585","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"Schadendorf","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0590","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002371-200501000-00007","article-title":"Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy","volume":"28","author":"Zhou","year":"2005","journal-title":"J. Immunother."},{"key":"10.1016\/j.molmed.2016.10.002_bib0595","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2016.10.002_bib0600","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1158\/0008-5472.CAN-15-0584","article-title":"Tumor-specific effector CD8+ T cells that can establish immunological memory in humans after adoptive transfer are marked by expression of IL7 receptor and c-Myc","volume":"75","author":"Chandran","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2016.10.002_bib0605","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrg3623","article-title":"Dynamic regulation of transcriptional states by chromatin and transcription factors","volume":"15","author":"Voss","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2016.10.002_bib0610","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature05918","article-title":"Stability and flexibility of epigenetic gene regulation in mammalian development","volume":"447","author":"Reik","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.10.002_bib0615","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2016.10.002_bib0620","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tig.2014.04.004","article-title":"Mechanisms of epigenetic memory","volume":"30","author":"D\u2019Urso","year":"2014","journal-title":"Trends Genet."},{"key":"10.1016\/j.molmed.2016.10.002_bib0625","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/eji.201545550","article-title":"Generating long-lived CD8 T cell memory: insights from epigenetic programs","volume":"46","author":"Dogra","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0630","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.4049\/jimmunol.1301395","article-title":"Global DNA methylation remodeling accompanies CD8 T cell effector function","volume":"191","author":"Scharer","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0635","doi-asserted-by":"crossref","first-page":"15306","DOI":"10.1073\/pnas.1112520108","article-title":"Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells","volume":"108","author":"Denton","year":"2011","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2016.10.002_bib0640","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ni.3198","article-title":"Regulation of DNA methylation dictates CD4 expression during the development of helper and cytotoxic T cell lineages","volume":"16","author":"Sellars","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0645","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.4049\/jimmunol.1003741","article-title":"Cutting edge: persistently open chromatin at effector gene loci in resting memory CD8+ T cells independent of transcriptional status","volume":"186","author":"Zediak","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0650","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.4049\/jimmunol.180.12.8102","article-title":"Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B)","volume":"180","author":"Araki","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0655","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.immuni.2014.11.001","article-title":"Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8 T cell differentiation","volume":"41","author":"Russ","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2016.10.002_bib0660","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.4049\/jimmunol.176.7.4083","article-title":"Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells","volume":"176","author":"Kersh","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0665","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/cmi.2015.32","article-title":"Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape","volume":"13","author":"Crompton","year":"2015","journal-title":"Cell. Molecul. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0670","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3643","article-title":"Adoptive cellular therapy: a race to the finish line","volume":"7","author":"June","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0675","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-11-1920","article-title":"The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer","volume":"18","author":"Lee","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2016.10.002_bib0680","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.it.2015.06.004","article-title":"Engineering CAR-T cells: design concepts","volume":"36","author":"Srivastava","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0685","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2016.10.002_bib0690","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0695","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0700","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0705","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrclinonc.2016.65","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0710","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1074-7613(00)80092-8","article-title":"The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery","volume":"11","author":"Ernst","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2016.10.002_bib0715","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.1124228","article-title":"Naive and memory CD4+ T cell survival controlled by clonal abundance","volume":"312","author":"Hataye","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.molmed.2016.10.002_bib0720","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.immuni.2009.09.015","article-title":"A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy","volume":"31","author":"Turtle","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2016.10.002_bib0725","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","article-title":"Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15","volume":"123","author":"Xu","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2016.10.002_bib0730","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1172\/JCI81217","article-title":"Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy","volume":"126","author":"Klebanoff","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molmed.2016.10.002_bib0735","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0740","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2016.10.002_bib0745","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1101\/gad.169029.111","article-title":"Immune microenvironments in solid tumors: new targets for therapy","volume":"25","author":"Shiao","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2016.10.002_bib0750","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/mt.2014.91","article-title":"Epigenetic manipulation restores functions of defective CD8+ T cells from chronic viral infection","volume":"22","author":"Zhang","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2016.10.002_bib0755","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1158\/0008-5472.CAN-15-2125","article-title":"Combining epigenetic and immunotherapy to combat cancer","volume":"76","author":"Chiappinelli","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2016.10.002_bib0760","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2015.10.020","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"164","author":"Chiappinelli","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.10.002_bib0765","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2016.10.002_bib0770","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1158\/0008-5472.CAN-11-1620","article-title":"Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape","volume":"72","author":"Woo","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2016.10.002_bib0775","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0780","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2016.10.002_bib0785","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.10.002_bib0790","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2326-6066.CIR-15-0073","article-title":"Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian cancer model","volume":"3","author":"Wang","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molmed.2016.10.002_bib0795","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/imr.12132","article-title":"Exploiting the curative potential of adoptive T-cell therapy for cancer","volume":"257","author":"Hinrichs","year":"2014","journal-title":"Immunol. Rev."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491416301447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491416301447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T23:57:58Z","timestamp":1536278278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491416301447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1471491416301447"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2016.10.002","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-Intrinsic Barriers of T Cell-Based Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2016.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}